Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Psychiatry > Antidepressants > Flashcards

Antidepressants Flashcards

1
Q

How does the efficacy of different antidepressants differ?

A

Antidepressant efficacy is similar so selection is based on past history of a response, side effect profile and coexisting medical conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

There is a delay typically of ____weeks after a therapeutic dose is achieved before symptoms improve.

A

2-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

If no improvement is seen after a trial of adequate length (________) and adequate dose, either switch to another antidepressant or augment with another agent.

A

at least 2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the prophylaxis; how long should a patient keep taking anti-depressants even if they feel better after a depressive episode?

A
  • First episode continue for 6mth to a year
  • Second episode continue for 2 years
  • Third episode disucuss life long
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give 5 classifications of antidepressants

A
  1. Tricyclics (TCAs)
  2. Monoamine Oxidase Inhibitors (MAOIs)
  3. Selective Serotonin Reuptake Inhibitors (SSRIs)
  4. Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  5. Novel antidepressants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tricyclic antidepressants (TCA) are very effective but have a potentially unacceptable side effect profile i.e.???

A
  • antihistaminic, anticholinergic, antiadrenergic
  • Lethal in overdose (even a one week supply can be lethal!)
  • Can cause QT lengthening even at a therapeutic serum level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tertiary TCAs have tertiary ______ side chains

A

Amine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tertiary TCAs have tertiary amine side chains.

Side chains are prone to? Give examples

A

Cross react with other types of receptors which leads to more side effects

Examples:

  • Imipramine
  • amitriptyline
  • doxepin
  • clomipramine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Secondary tricyclic antidepressants (TCAs) are of metabolites of which amines?

A

Tertiary amines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do secondary tricyclic antidepressants work?

A

primarily block noradrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the side-effects of secondary TCAs?

Give examples

A

Side chains are prone to cross react with other types of receptors which leads to more side effects

  • Desipramine
  • notrtriptyline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

How do MAOIs work?

A

Bind irreversibly to monoamine oxidase thereby preventing inactivation of amines such as norepinephrine, dopamine and serotonin leading to increased synaptic levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

MAOIs aree very effective for what type of depression?

A

Are very effective for resistant depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

MAOIs have what side effects?

A
  • Side effects include orthostatic hypotension
  • weight gain
  • dry mouth
  • sedation
  • sexual dysfunction
  • sleep disturbance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

MAOIs can have a “cheese reaction”… what is it?

A

Hypertensive crisis can develop when MAOI’s are taken with tyramine-rich foods or sympathomimetics. *Cheese + Wine Reaction!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Which foods and drinks must patients taking MAOIs stay away from?

Why?

A

Hypertensive crisis can develop when MAOI’s are taken with tyramine-rich foods or sympathomimetics.

*Cheese + Wine Reaction!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

What can happen if you take MAOIs with meds that increase serotonin or have a sympathomimetic action?

A

Serotonin syndrome

  • abdominal pain
  • diarrhea
  • sweats
  • tachycardia
  • HTN
  • myoclonus
  • irritability
  • delirium
  • Can lead to hyperpyrexia
  • cardiovascular shock and death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

If MAOIs are taken with meds that increase serotonin or have a sympathomimetic action it can cause serotonin syndrome… what are the symptoms?

A

Serotonin syndrome

  • abdominal pain
  • diarrhea
  • sweats
  • tachycardia
  • HTN
  • myoclonus
  • irritability
  • delirium
  • Can lead to hyperpyrexia
  • cardiovascular shock and death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

If MAOIs are taken with meds that increase serotonin or have a sympathomimetic action it can cause serotonin syndrome… How can you avoid this from happening?

A

To avoid need to wait 2 weeks before switching from an SSRI to an MAOI.

The exception of fluoxetine where need to wait 5 weeks because of long half-life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

How do selective serotonin reuptake inhibitors (SSRIs) work?

A

Block the presynaptic serotonin reuptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

What are SSRIs they used to treat?

A

Treat both anxiety and depressive sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

What are the most common side-effects of SSRIs?

A

Most common side effects include

  • GI upset, sexual dysfunction (30%+!)
  • anxiety
  • restlessness
  • nervousness
  • insomnia
  • fatigue or sedation
  • dizziness​

*Very little risk of cardiotoxicity in overdose

23
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

What syndrome might patients develop if SSRIs are stopped too quickly?

A

Can develop a discontinuation syndrome if drug stopped too quickly with

  • agitation
  • nausea
  • disequilibrium
  • dysphoria
24
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

One draw back of using SSRIs is that some patients experience activation syndrome as they go onto it.

What is it caused by and what is it?

A

Activation Syndrome: Cause increased serotonin. Can be distressing for patient.

  • Nausea
  • increased anxiety
  • panic
  • agitation.
25
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

One draw back of using SSRIs is that some patients experience activation syndrome as they go onto it. Cause increased serotonin. Can be distressing for patient .

How long does it last for?

A

Typically last 2 – 10 days Warn patients!

26
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

If SSRIs are stopped too quickly it can cause discontinuation syndrome.

What are the symptoms and what is the solution?

A
  • agitation
  • nausea
  • disequilibrium
  • dysphoria

More common with shorter half-life drugs so consider switching to fluoxetine (type of SSRI) .

27
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Paroxetine is a type of SSRI.

What are the pros?

A
  • Short half life with no active metabolite means no build-up (which is good if hypomania develops)
  • Sedating properties (dose at night) offers good initial relief from anxiety and insomnia
28
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Paroxetine is a type of SSRI.

What are the cons?

A
  • Sedating
  • wt gain
  • more anticholinergic effects
  • Likely to cause a discontinuation syndrome
29
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Sertraline is a type of SSRI.

What are the pros?

A
  • Very weak P450 interactions (only slight CYP2D6)
  • Short half life with lower build-up of metabolites
  • Less sedating when compared to paroxetine
30
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Sertraline is a type of SSRI.

What are the cons?

A
  • Max absorption requires a full stomach
  • Increased number of GI adverse drug reactions
31
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Fluoxetine (prozac) is a type of SSRI.

What are the pros?

A
  • Long half-life so decreased incidence of discontinuation syndromes. Good for pts with medication noncompliance issues
  • Initially activating so may provide increased energy
  • Secondary to long half life, can give one 20mg tab to taper someone off SSRI when trying to prevent SSRI Discontinuation Syndrome
32
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Fluoxetine (prozac) is a type of SSRI.

What are the cons?

A
  • Long half life and active metabolite may build up (e.g. not a good choice in patients with hepatic illness)
  • Significant P450 interactions so this may not be a good choice in pts already on a number of meds
  • Initial activation may increase anxiety and insomnia
  • More likely to induce mania than some of the other SSRIs
33
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Citalopram is a type of SSRI.

What are the pros?

A
  • Low inhibition of P450 enzymes so fewer drug-drug interactions
  • Intermediate ½ life
34
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Citalopram is a type of SSRI.

What are the cons?

A
  • Dose-dependent QT interval prolongation with doses of 10-30mg daily- due to this risk doses of >40mg/day not recommended!
  • Can be sedating (has mild antagonism at H1 histamine receptor)
  • GI side effects (less than sertraline)
35
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Escitalopram is a type of SSRI.

What are the pros?

A
  • Low overall inhibition of P450s enzymes so fewer drug-drug interactions
  • Intermediate 1/2 life
  • More effective than Citalopram in acute response and remission
36
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Escitalopram is a type of SSRI.

What are the cons?

A
  • Dose-dependent QT interval prolongation with doses of 10-30mg daily
  • Nausea, headache
37
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Fluvoxamine is a type of SSRI.

What are the pros?

A
  • Shortest ½ life
  • Found to possess some analgesic properties
38
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Fluvoxamine is a type of SSRI.

What are the cons?

A
  • Shortest ½ life
  • GI distress, headaches, sedation, weakness
  • Strong inhibitor of CYP1A2 and CYP2C19
39
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

How do SNRIs work?

A

Inhibit both serotonin and noradrenergic reuptake like the TCAS but without the antihistamine, antiadrenergic or anticholinergic side effects

40
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

What are SNRIs used for?

A
  • Used for depression
  • anxiety
  • possibly neuropathic pain
41
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Venlafaxine is a type of SNRI.

What are the pros?

A
  • Minimal drug interactions and almost no P450 activity
  • Short half life and fast renal clearance avoids build-up (good for geriatric populations)
42
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Venlafaxine is a type of SNRI.

What are the cons?

A
  • Can cause a 10-15 mmHG dose dependent increase in diastolic BP.
  • May cause significant nausea, primarily with immediate-release (IR) tabs
  • Can cause a bad discontinuation syndrome, and taper recommended after 2 weeks of administration
  • Noted to cause QT prolongation
  • Sexual side effects in >30%
43
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Duloxetine is a type of SNRI.

What are the pros?

A
  • Some data to suggest efficacy for the physical symptoms of depression
  • Thus far less BP increase as compared to venlafaxine, however this may change in time
44
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Duloxetine is a type of SNRI.

What are the cons?

A
  • CYP2D6 and CYP1A2 inhibitor
  • Cannot break capsule, as active ingredient not stable within the stomach
  • In pooled analysis had higher drop out rate
45
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Mirtazapine is a novel antidepressant.

What are the pros?

A
  • Different mechanism of action may provide a good augmentation strategy to SSRIs. Is a 5HT2 and 5HT3 receptor antagonist
  • Can be utilized as a hypnotic at lower doses secondary to antihistaminic effects
46
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Mirtazapine is a novel antidepressant.

What are the cons?

A
  • Increases serum cholesterol by 20% in 15% of patients and triglycerides in 6% of patients
  • Very sedating at lower doses. At doses 30mg and above it can become activating and require change of administration time to the morning.
  • Associated with weight gain (particularly at doses below 45mg
47
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Mirtazapine is a novel antidepressant.

What are the cons?

A
  • Increases serum cholesterol by 20% in 15% of patients and triglycerides in 6% of patients
  • Very sedating at lower doses. At doses 30mg and above it can become activating and require change of administration time to the morning.
  • Associated with weight gain (particularly at doses below 45mg
48
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Buproprion is a novel antidepressant.

What are the pros?

A
  • Good for use as an augmenting agent
  • Mechanism of action likely reuptake inhibition of dopamine and norepinephrine
  • No weight gain, sexual side effects, sedation or cardiac interactions
  • Low induction of mania
  • Is a second line ADHD agent so consider if patient has a co-occurring diagnosis
49
Q

Antidepressants used in psychiatry fall into the following categories;

  • Tricyclics (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)
  • Novel antidepressants

Buproprion is a novel antidepressant.

What are the cons?

A
  • May increase seizure risk at high doses (450mg+) and should avoid in patients with Traumatic Brain Injury, bulimia and anorexia.
  • Does not treat anxiety unlike many other antidepressants and can actually cause anxiety, agitation and insomnia
  • Has abuse potential because can induce psychotic sx at high doses
50
Q

Case 1

  • Susie has a nonpsychotic unipolar depression with no history of hypomania or mania. She has depressed mood, hyperphagia, psychomotor retardation and hypersomnolence. What agent would you like to use for her?
  • Establish dx: Major depressive disorder
  • Target symptoms: depression, hyperphagia, psychomotor retardation and hypersomnolence

How should you treat her?

A

For a treatment naive patient start with an SSRI.

Using the side effect profile as a guide select an SSRI that is less sedating.

Good choices would be

  • Citalopram
  • Fluoxetine
  • Sertraline
51
Q

Case 1

  • Susie has a nonpsychotic unipolar depression with no history of hypomania or mania. She has depressed mood, hyperphagia, psychomotor retardation and hypersomnolence. What agent would you like to use for her?
  • Establish dx: Major depressive disorder
  • Target symptoms: depression, hyperphagia, psychomotor retardation and hypersomnolence

How should you treat her?

A

For a treatment naive patient start with an SSRI.

Using the side effect profile as a guide select an SSRI that is less sedating.

Good choices would be

  • Citalopram
  • Fluoxetine
  • Sertraline
52
Q

Case 1

  • Susie has a nonpsychotic unipolar depression with no history of hypomania or mania. She has depressed mood, hyperphagia, psychomotor retardation and hypersomnolence. What agent would you like to use for her?
  • Establish dx: Major depressive disorder
  • Target symptoms: depression, hyperphagia, psychomotor retardation and hypersomnolence

How should you NOT treat her?

A
  • Less desirable choices include Paroxetine and Mirtazapine because of sedation and wt gain.
  • Not a duel reuptake inhibitors because she is treatment naïve.
  • Not a TCA because of side effects

Instead, use an SSRI for naive patients;

  • Citalopram
  • Fluoxetine
  • Sertraline
53
Q

Case 2

ob is a 55 year old diabetic man with mild HTN and painful diabetic neuropathy who has had previous depressive episodes and one suicide attempt. He meets criteria currently for a major depressive episode with some anxiety. He has been treated with paroxetine, sertraline and buproprion. His depression was improved slightly with each of these meds but never remitted. What would you like to treat him with?

  • Establish dx: Major depressive disorder with anxious features
  • Target symptoms: depressive sx, anxiety and possibly his neuropathic pain
A

Assuming he received adequate trials previously would move on to a duel reuptake inhibitor as he had not achieved remission with two SSRIS or a novel agent.

  • Given his mild HTN would not choose Venlafaxine.
  • TCA’s can help with neuropathic pain and depression however not a good choice given the SE profile and lethality in overdose.

DRUG of Choice = Duloxetine

  • Duloxetine is a good choice since it has an indication for neuropathic pain, depression and anxiety. Three birds with one stone!!
  • Keep in mind Duloxetine is a CYP2D6 and CPY1A2 inhibitor and has potential drug-drug interactions.
54
Q

How should you treat a depressed patient with treatment resistance?

A
  • Combination of antidepressants eg SSRI or SNRI (venlafaxine) with Mirtazepine
  • Adjunctive treatment with Lithium
  • Adjunctive treatment with atypical antipsychotic eg Quetipaine, Olanzapine or Aripiprazole
  • ECT!!

Psychiatry (21 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions